Jonathan Izudi
ID: UNCST-2019-R000469
|
Integrating Tuberculosis Treatment into Community Pharmacies to improve TB/HIV outcomes in Uganda: the Community Pharmacy Tuberculosis Treatment (COPHAT) study
REFNo: HS4397ES
To evaluate the implementation and preliminary effectiveness of integrating TB treatment into community pharmacies among people with TB/HIV.,To adapt a person-centered strategy for integrating TB treatment into community pharmacies using a human-centered design methodology.,To explore the barriers and facilitators to integrating TB treatment into community pharmacies among people with TB/HIV.,The main objective of this Community Pharmacy Tuberculosis Treatment (COPHAT) study is to develop and pilot an implementation strategy focused on integrating TB treatment into community pharmacies among people with TB/HIV in Kampala, Uganda. ,
|
Uganda |
2024-06-21 17:46:35 |
2027-06-21 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
.jpg)
|
JUSTINE MUKALERE
ID:
|
CONNECTING COMMUNITIES TO HEALTH SYSTEMS THROUGH VILLAGE HEALTH TEAMS: A TECHNOLOGY-ENABLED FRAMEWORK. A CASE OF BUGWERI, BULAMBULI, KIBUKU DISTRICTS
REFNo: SIR284ES
iii. To evaluate the designed framework to establish its applicability in connecting communities to health systems.,ii. To design a technology-enabled framework that will connect villages to health systems through Village Health Teams,i. To study the challenges faced by Village Health Teams in Kibuku, Bulambuli and Bugweri districts based on the existing framework and generate requirements,To enhance the connectivity between communities and the health systems through Village Health Teams based on a technology-enabled framework.,
|
Uganda |
2024-06-21 17:45:14 |
2027-06-21 |
Engineering and Technology |
Non-Clinical Trial |
Degree Award |
|
Leticia Kyohangirwe
ID: UNCST-2024-R004144
|
Determining the effect of psychiatric disorders on clinical outcomes among
adolescents with HIV in Uganda over a one-year period.
REFNo: HS4120ES
The overall objective is to determine effect of psychiatric disorders on clinical outcomes among adolescents with HIV in Uganda using a longitudinal analysis approach.
|
Uganda |
2024-06-19 15:57:59 |
2027-06-19 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Kearsley Stewart
ID: UNCST-2021-R011830
|
Addressing Sickle Cell Disease in Uganda: A Multi-Sectoral Approach
REFNo: HS4276ES
Aim 3: We aim to assess the current digital capacity (smart mobile phone access, internet access, data security, access to data) of KHCIV sickle cell patients, their caregivers, and KHCIV clinic staff in order to understand their preparedness for using mobile applications to improve sickle cell disease care. We seek to identify facilitators and barriers to uptake of mHealth tools and interventions, including Nanbar Health for patients and SCD Toolbox for KHCIV providers. In addition, we aim to determine the feasibility of using the Nanbar Health and SCD Toolbox mobile applications in Kalangala District and propose solutions for adaptation to enhance sickle cell care and improve outcomes beyond Kalangala District for others in Uganda. ,Aim 2: We aim to improve clinical monitoring of home-based adherence to hydroxyurea by exploring the feasibility and acceptability of using a rapid point-of-care electrophoresis sickle cell test (Gazelle) to monitor fetal hemoglobin for sickle cell patients taking hydroxyurea at their quarterly clinic visits to KHCIV. In addition, we aim to understand the facilitators and barriers to successful home-based adherence to hydroxyurea through a home visit to interview patient and caregivers about their adherence-related behaviors and observe conditions in the home that directly influence adherence to hydroxyurea, such as pill storage. ,Aim 1: We aim to explore the facilitators and barriers to uptake of newborn screening at KHCIV at a time when the Government of Uganda is scaling up newborn sickle cell testing across the country. We will describe the challenges for staff at a remote government health care facility to scale up newborn sickle cell testing. We will study parental perspectives on newborn sickle cell testing and their experiences with the current standard-of-care (dried blood spots) sent by KHCIV to the Central Public Health Laboratory in Kampala.,This study aims to reduce the burden of SCD in Uganda through a multi-sectoral study of the facilitators and barriers to: scale-up of universal newborn screening, adherence to treatments such as hydroxyurea, and improved access to sickle cell health education through mHealth digital apps. ,
|
USA |
2024-06-18 11:20:00 |
2027-06-18 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Fred Nalugoda
ID: UNCST-2021-R013343
|
The Rakai Orphans in Communities (ROC)
REFNo: SS2744ES
The specific aims are to:
1. Define, over time, the potentially changing impact of orphanhood on HIV risk factors and HIV infection among AYA from RCCS Rounds 6-23 (1999-2027).
2. Explore issues related to mechanism and measurement to better understand the population burden of orphanhood among AYA. Key issues include 1-timing of orphaning (i.e., age they became an orphan), 2-influence of orphanhood vs. parental absence from the household, 3-the burden of orphanhood over time among children 0-14 years, and 4-validating the route of transmission (behavioral vs. perinatal) among adolescents first entering the RCCS.
3. Through life history interviews, explore the mechanisms by which orphanhood and age at orphaning may influence HIV risk among AYA and adolescent social outcomes and to assess how programs can be tailored to meet the needs of this vulnerable population. Interviews will be conducted with youth and their adult caretakers; each should be able to differentially report on events and circumstances of the orphaning period.
4. Estimate the economic impact of declining HIV-related orphanhood on youth, families, and communities. In a cost-benefit analysis, we will examine benefits of declining orphanhood (decreased adult mortality, decreased orphanhood, increased educational status, decreased HIV infection among youth) and costs (costs for ART, MMC).
|
Uganda |
2024-06-17 11:41:08 |
2027-06-17 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|